Thursday, April 25, 2024 9:18:16 AM
But how savvy is GIUL, considering that:
* GIUL signed that contract without reading it.
* GIUL initially sued Faupel and Blumberg for 10 counts, but the court threw out six of those before the case went to court.
* When the case went to court, the judge then threw out GIUL's conspiracy claims, leaving only three counts remaining.
https://masslawyersweekly.com/files/2024/03/09-024-24.pdf
I understand that this is common in law -- throw a bunch of spaghetti against a wall and see what sticks -- but getting seven out of 10 counts thrown out doesn't give me much confidence in GIUL.
And the trial changed from a jury trial to a Directed trial -- at whose request was that done, GIUL or Shenghou?
Regardless -- Guided Therapeutics is not a party to the case and so there are no claims in the case against Guided Therapeutics. I have no doubt that if GIUL loses the remaining three counts, GIUL will throw more spaghetti against the wall and bring more lawsuits, but this forum is a poor place to whine and complain about how poorly GIUL was treated and abused. A savvy legal expert would find a better way to air grievances.
Recent GTHP News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 06:36:25 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/20/2024 06:42:41 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 06:48:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 04:24:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 08:28:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2023 09:49:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2023 04:44:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/07/2023 07:53:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 07:00:31 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM